latest news releases from the newsroom
OMX AB's Nomination Committee
STOCKHOLM, Sweden, Nov. 08, 2004 (PRIMEZONE) -- In accordance with a decision made at OMX's Annual General Meeting on March 25, 2004, a Nomination Committee, consisting of representatives from the four largest shareholders in OMX AB and the Chairman of the Board of Directors, is hereby announced. The Nomination Committee shall, among other things, develop a proposal for the composition of the Board of Directors, which will be presented for approval at the next Annual General Meeting.
ADVA Optical Networking
ADVA Optical Networking Receives Brocade Fabric Aware Status For End-To-End Storage Networking Interoperability
MARTINSRIED and MUNICH, Germany and MAHWAH, N.J. Nov. 8, 2004 (PRIMEZONE) -- ADVA Optical Networking announced today that its FSP 2000 and FSP 3000 systems have been verified by Brocade as interoperable with Brocade-based Storage Area Networking (SAN) infrastructure, according to the testing requirements of the Brocade Fabric Aware Program, an end-to-end interoperability initiative for SANs. The program is a comprehensive testing and configuration initiative designed to foster SAN interoperability in multi-vendor Brocade-based SAN environments.
StockPickReport: Sun Microsystems Buy Rating
SHREVEPORT, La., Nov. 8, 2004 (PRIMEZONE) -- Stock-Letter-Daily.Com (http://www.stock-letter-daily.com - an affiliate site of StockPickReport, the web's only non-mainstream stock rating service), rates Sun Microsystems, Nokia Corporation, Liberty Media Corporation CL A, DIAMONDS
StockPickReport: Qualcomm Sell Rating
SHREVEPORT, La., Nov. 8, 2004 (PRIMEZONE) -- Stock-Letter-Daily.Com (http://www.stock-letter-daily.com -- an affiliate site of StockPickReport, the web's only non-mainstream stock rating service), rates QUALCOMM Incorporated, Nextel Communications, Inc., Isonics Corporation, Ford Motor Company.
Symbollon Pharmaceuticals, Inc
Symbollon Pharmaceuticals Announces Completion of Private Placement to Accredited Investors
FRAMINGHAM, Mass., Nov. 8, 2004 (PRIMEZONE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) today announced the completion of a private placement to accredited investors for an aggregate of 1,261,692 shares of Class A common stock and 630,846 redeemable warrants for $634,300 in cash and $185,800 in prepaid manufacturing, consulting and clinical trial services ($1.30 for two shares and one warrant).